Psychic disturbances associated with sodium valproate plus levetiracetam.
Siniscalchi
Antonio
A
Gallelli
Luca
L
De Fazio
Salvatore
S
De Sarro
Giovambattista
G
D000927:Anticonvulsants / Q000009:adverse effects*; D001007:Anxiety / Q000139:chemically induced*; D004359:Drug Therapy, Combination; D004828:Epilepsies, Partial / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000077287:Levetiracetam; D008875:Middle Aged; D010889:Piracetam / Q000009:adverse effects / Q000031:analogs & derivatives*; D011595:Psychomotor Agitation; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced; D014635:Valproic Acid / Q000009:adverse effects*
D000927:Anticonvulsants; D000077287:Levetiracetam; D014635:Valproic Acid; D010889:Piracetam